PF-Atlas › Drugs › Lactobacillus reuteri

Lactobacillus reuteri

Idiopathic Pulmonary Fibrosis

Clinical trials
1
Developer
Azienda Policlinico Umberto I

Overview

Lactobacillus reuteri is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.

Lactobacillus reuteri clinical trials

Explore related

Medical disclaimer. This page summarizes research about Lactobacillus reuteri for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.